Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2023-11-30 00:00:00 ET · period of report 2023-11-28 · accession 0001209191-23-056987 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-11-30 | 2023-11-28 | CADL | Tak Paul Peter | CEO, Dir | F - Tax | $0.9 | -43.4K | 373.6K | -10% | -$39.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-11-28 | F | D | 43,443 | $0.9 | 373,556 | D | — | — | (F1) These shares were withheld by the Issuer to satisfy tax withholding obligations associated with the vesting and settlement of restricted stock units. |